Clinical study of periocline on peri-implantitis treatment.
- Author:
Li ZHOU
1
;
Ye LIN
;
Li-xin QIU
;
Bo CHEN
;
Xiu-lian HU
;
Xin WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Anti-Bacterial Agents; therapeutic use; Dental Implantation, Endosseous; adverse effects; Dental Implants; adverse effects; Female; Humans; Male; Middle Aged; Minocycline; therapeutic use; Periodontitis; drug therapy; etiology
- From: Chinese Journal of Stomatology 2006;41(5):299-303
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the clinical outcome and the effects of treating peri-implantitis with periocline.
METHODSThirty-two sites in 32 implants with peri-implantitis were treated with periocline. The parameters including plaque index, probing depth (PD) of pocket, sulcular bleeding index (SBI) were measured at baseline, 1, 3, 6 and 12 weeks after treatment and followed up for 6 months.
RESULTSStatistically significant decrease (P < 0.05) in SBI, and PD occurred at all time intervals compared to baseline. The treatment could last for at lest four weeks in peri-implantitis cases without fistula.
CONCLUSIONSPeriocline could be safely and effectively used in treating peri-implantitis in cases without peri-implant fistula. Peri-implantitis with fistula should be treated in combination with surgical methods, and periocline can also be used to control inflammation before surgery.
